2023, Number 05
<< Back Next >>
Ginecol Obstet Mex 2023; 91 (05)
Factors associated with the acceptance of vaccination against SARS-CoV-2 in Peruvian pregnant women, 2022
Fajardo-Benavides JF, Santos-Rosales YR, Chilipio-Chicclla MA, Valverde-Espinoza N
Language: Spanish
References: 31
Page: 291-298
PDF size: 212.52 Kb.
ABSTRACT
Objective: We describe the acceptance of the SARS-CoV-2 vaccine in Peruvian
pregnant women and associated factors during 2022.
Methods: Observational, analytical, cross-sectional and retrospective study with
a sample of 315 pregnant women selected by simple random sampling, January to
June 2022.
Results: The acceptance rate of the SARS-CoV-2 vaccine was 58.1%. Of the total
number of immunized women, 96.2% had two doses and 3.8% had only one dose;
the main reason for having only one dose was having been ill with COVID-19 and
one dose was sufficient (42.8%) while the main reason for not having any dose was
the fear that the vaccine would harm the baby (40.1%). Regarding associated factors
dependent work obtained a Prevalence Ratio (Rp= 2.18) CI95% [1.13-4.18; p=0.019]
and previous SARS-CoV-22 infection an Rp= 2.41 CI95% [1.03-5.59; p=0.040].
Conclusion: more than one third of pregnant women did not accept vaccination
against SARS-CoV-2; factors associated with acceptance of vaccination against
COVID-19 were a history of SARS-CoV-2 infection and performing dependent work.
REFERENCES
Carrillo-Mora P, García-Franco A, Soto-Lara M, Rodríguez-Vásquez G, Pérez-Villalobos J, Martínez-Torres D. Cambiosfisiológicos durante el embarazo normal. Rev Fac Med(Méx) 2021; 64(1): 39-48. https://doi.org/10.22201/fm.24484865e.2021.64.1.07
Magon N, Prasad S, Mahato C, Sharma JB. COVID-19 vaccineand pregnancy: A safety weapon against pandemic.Taiwan J Obstet Gynecol 2022; 61 (2): 201-9. doi: 10.1016/j.tjog.2022.02.005
Vigil-De Gracia Paulino, Caballero Luis Carlos, Ng ChinkeeJorge, Luo Carlos, Sánchez Jaime, Quintero Arelys, etal. COVID-19 y embarazo. Revisión y actualización. RevPeru Ginecol Obstet 2020; 66 (2): 00006. http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322020000200006&lng=es. http://dx.doi.org/10.31403/rpgo.v66i2248
Hijona Elósegui AL, Carballo Garcíaa AC, Fernández RisquezM, Bermúdez Quintanaa JF.. Does the maternal-fetaltransmission of SARS-CoV-2 occur during pregnancy? RevClin Esp 2020; 221 (2): 93-6. https://doi.org/10.1016/j.rce.2020.06.001
Rasmussen SA, Jamieson DJ. COVID-19 and Pregnancy.Infect Dis Clin North Am 2022; 36 (2): 423-33. https://doi.org/10.1016/j.idc.2022.01.002
Poblete C, Bancalari A. Transmisión vertical de COVID-19.¿Qué dice la evidencia? Andes Pediatr 2021; 92 (5): 790-98. http://dx.doi.org/10.32641/andespediatr.v92i5.3488
Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ,Denison F, Maybin JA. Pregnancy and COVID-19. PhysiolRev 2020; 101 (1): 303-18. https://doi.org/10.1152/physrev.00024.2020
Wang ChL, Yi-Yin L, Wu Chin-Hu, Wang Chun-Yu, et al.Impact of COVID-19 on Pregnancy. Int J Med Sci 2021; 18(3): 763-67. https://doi.org/10.7150/ijms.49923
Nana M, Nelson-Piercy C. COVID-19 in pregnancy. Clin Med(Lond) 2021; 21 (5): e446-e450. https://doi.org/10.7861/clinmed.2021-0503
WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int
Hernández-Moraima CA, Rísquez A, Guzmán M, CabreraC, Drummond T. Consenso de la COVID-19 en el embarazo.Bol Venez Infectol 2021; 32 (1): 7-26. Disponible en:https://docs.bvsalud.org/biblioref/2021/07/1255046/01-hernandez-m-7-26.pdf
Ramos M. Mortalidad materna, ¿cambiando la causalidadel 2021? Rev Peru Ginecol Obstet 2022; 68 (1): 00018.http://dx.doi.org/10.31403/rpgo.v68i2407
Whitehead CL, Walker SP. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Lancet2020; 395 (10237): e92. https://doi.org/10.1016/S0140-6736(20)31029-1
Dashraath P, Nielsen-Saines K, Madhi SA, Baud D.COVID-19 vaccines and neglected pregnancy. Lancet2020; 396 (10252): e22. https://doi.org/10.1016/S0140-6736(20)31822-5
Beharier O, Plitman R, Raz T, Nahum K, Schreiber L, Suissa-Cohen Y, et al. Efficient maternal to neonatal transfer ofantibodies against SARS-CoV-2 and BNT162b2 mRNACOVID-19 vaccine. J Clin Invest 2021; 131 (13): e150319.https://www.jci.org/articles/view/150319?elqTrackId=9f9b091c7be14f0dbe31bcce84fc2434
Bleicher I, Kadour-Peero E, Sagi-Dain L, Sagi S. Early explorationof COVID-19 vaccination safety and effectivenessduring pregnancy: interim descriptive data from a prospectiveobservational study. Vaccine 2021; 39 (44): 6535-38.https://doi.org/10.1016/j.vaccine.2021.09.043
Caycho-Rodríguez T, Gallegos M, Valencia PD, Vilca LW.¿How much do Peruvians support conspiracy beliefs aboutCOVID-19 vaccines? Aten Primaria. 2022; 54 (5): 102318.https://doi.org/10.1016/j.aprim.2022.102318
González-Melado FJ, Di Pietro ML. The vaccine against COVID-
19 and institutional trust. Enferm Infecc Microbiol Clin(Engl Ed) 2020; 39 (10): 510-15. https://doi.org/10.1016/j.eimc.2020.08.00119. Hala Q, Ibtesam A, Hadeel M, Beesan M, Ahmad M,Lama Q, et al. Perceived barriers to Palestinian pregnantwomen’s acceptance of COVID-19 vaccination using theHealth Believe Model: a cross-sectional study. Women& Health 2022; 62: 8: 678-87. doi:10.1080/03630242.
2022.210819420. Örtqvist AK, Dahlqwist E, Magnus MC, Ljung R, Jonsson BA,et al. COVID-19 vaccination in pregnant women in Swedenand Norway. Vaccine 2022; 40 (33): 4686-92. https://doi.org/10.1016/j.vaccine.2022.06.083
Nemat A, Yaftali S, Danishmand TJ, Nemat H, Nahid Raufi,Abdullah Asady. High rates of COVID-19 vaccine refusalamong Afghan pregnant women: a cross sectional study.Sci Rep 2022; 12 (1): 14057. https://doi.org/10.1038/s41598-022-18497-x
Chekol E, Ayalew G, Asmare G, Mengie T, Tilahun Z, BehaileA, et al. COVID-19 vaccine uptake and associated factorsamong pregnant women attending antenatal care inDebre Tabor public health institutions: A cross-sectionalstudy. Front Public Health 2022; 10: 919494. https://doi.org/10.3389/fpubh.2022.919494
Azami M, Nasirkandy MP, Esmaeili H, Ranjbar R. COVID-19vaccine acceptance among pregnant women worldwide:A systematic review and meta-analysis. PLoS One.2022;17(9):e0272273. https://doi.org/10.1371/journal.pone.0272273
Nachega JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ,Mellors JW, Zumla A, et al. Prioritizing Pregnant Womenfor Coronavirus Disease 2019 Vaccination in African Countries.Clin Infect Dis. 2022; 75 (8): 1462-66. https://doi.org/10.1093/cid/ciac362
Gunawardhana N, Baecher K, Boutwell A, Pekwarake S, KifemM, Ngong MG, et al. COVID-19 vaccine acceptance andperceived risk among pregnant and non-pregnant adults inCameroon, Africa. PLoS One 2022; 17 (9): e0274541. doi:10.1371/journal.pone.0274541
Naqvi S, Saleem S, Naqvi F, Billah SM, Nielsen E, FoglemanE, et al. Knowledge, attitudes, and practices of pregnantwomen regarding COVID-19 vaccination in pregnancy in7 low- and middle-income countries: An observationaltrial from the Global Network for Women and Children'sHealth Research. BJOG 2022; 129 (12): 2002-9. https://doi.org/10.1111/1471-0528.17226
Gupta A, Christina S, Umar AY, Laishram J, Akoijam BS. COVID-19 Vaccine hesitancy among pregnant women: A facilitybasedcross-sectional study in Imphal, Manipur. Indian J PublicHealth 2022; 66 (2): 98-103. doi:10.4103/ijph.ijph_1826_21
Issaris V, Kalogerakos G, Milas GP. Vaccination hesitancyamong greek orthodox christians: is there a conflict betweenreligion and science? J Relig Health 2023; 9: 1-6.https://doi.org/10.1007/s10943-023-01759-x
Levy AT, Singh S, Riley LE, Prabhu M. Acceptance of COVID-19 vaccination in pregnancy: a survey study. Am JObstet Gynecol MFM 2021; 3 (5): 100399. https://doi.org/10.1016/j.ajogmf.2021.100399
Riad A, Jouzová A, Üstün B, Lagová E, Hruban L, et al.COVID-19 Vaccine Acceptance of Pregnant and LactatingWomen (PLW) in Czechia: An Analytical Cross-SectionalStudy. Int J Environ Res Public Health 2021; 18 (24): 13373.https://doi.org/10.3390/ijerph182413373
Ghamri RA, Othman SS, Alhiniah MH, Alelyani RH, AtheerM Badawi & Asma A Alshahrani. Acceptance of COVID-19vaccine and associated factors among pregnant women inSaudi Arabia. Patient Prefer Adherence 2022; 16: 861-73.doi: 10.2147/PPA.S357653